Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents

Bryan Bednarz, Joseph Grudzinski, Ian Marsh, Abby Besemer, Dana Baiu, Jamey Weichert, Mario Otto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There is a growing need to estimate the absorbed dose to small animals from preclinical investigations involving diagnostic and therapeutic radiopharmaceuticals. This paper introduces a Monte Carlo-based dosimetry platform called RAPID, which is capable of calculating murine-specific three-dimensional (3D) dose distributions. A comparison is performed between absorbed doses calculated with RAPID and absorbed doses calculated in a commonly used reference mouse phantom called MOBY. Four test mice containing different xenografts underwent serial PET/CT imaging using a novel diagnostic therapy (theranostic) agent NM404, which can be labeled with 124I for imaging or 131I for therapy. Using the PET/CT data, 3D dose distributions from 131I-NM404 were calculated in the mice using RAPID. Mean organ doses in these four test mice were compared to mean organ doses derived by using two previously published 131I S-values datasets in MOBY. In addition, mean tumor doses calculated in RAPID were compared to mean organ doses derived from unit density spheres. Large differences were identified between mean organ doses calculated in the test mice using RAPID and those derived in the MOBY phantom. Mean absorbed dose percent errors in organs ranged between 0.3% and 333%. Overall, mass scaling improved agreement between MOBY phantom calculations and RAPID, where percent errors were all less than 26%, with the exception of the lung in which percent errors reached values of 48%. Percent errors in mean tumor doses in the test mice and unit density spheres were less pronounced but still ranged between 8% and 23%. This work demonstrates the limitations of using pre-computed S-values in computational phantoms to predict organ doses in small animals from theranostic procedures. RAPID can generate accurate 3D dose distributions in small animals and in turn offer much greater insight on the ability of a given theranostic agent to image and treat diseases.

Original languageEnglish (US)
Pages (from-to)450-459
Number of pages10
JournalHealth Physics
Volume114
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Therapeutics
Radiopharmaceuticals
Heterografts
Neoplasms
Lung
Theranostic Nanomedicine
Datasets

Keywords

  • Monte Carlo
  • dosimetry, internal
  • nuclear medicine
  • radiation therapy

ASJC Scopus subject areas

  • Epidemiology
  • Radiology Nuclear Medicine and imaging
  • Health, Toxicology and Mutagenesis

Cite this

Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. / Bednarz, Bryan; Grudzinski, Joseph; Marsh, Ian; Besemer, Abby; Baiu, Dana; Weichert, Jamey; Otto, Mario.

In: Health Physics, Vol. 114, No. 4, 01.04.2018, p. 450-459.

Research output: Contribution to journalArticle

Bednarz, Bryan ; Grudzinski, Joseph ; Marsh, Ian ; Besemer, Abby ; Baiu, Dana ; Weichert, Jamey ; Otto, Mario. / Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. In: Health Physics. 2018 ; Vol. 114, No. 4. pp. 450-459.
@article{1965c957214842a1847a67c0857d2d3d,
title = "Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents",
abstract = "There is a growing need to estimate the absorbed dose to small animals from preclinical investigations involving diagnostic and therapeutic radiopharmaceuticals. This paper introduces a Monte Carlo-based dosimetry platform called RAPID, which is capable of calculating murine-specific three-dimensional (3D) dose distributions. A comparison is performed between absorbed doses calculated with RAPID and absorbed doses calculated in a commonly used reference mouse phantom called MOBY. Four test mice containing different xenografts underwent serial PET/CT imaging using a novel diagnostic therapy (theranostic) agent NM404, which can be labeled with 124I for imaging or 131I for therapy. Using the PET/CT data, 3D dose distributions from 131I-NM404 were calculated in the mice using RAPID. Mean organ doses in these four test mice were compared to mean organ doses derived by using two previously published 131I S-values datasets in MOBY. In addition, mean tumor doses calculated in RAPID were compared to mean organ doses derived from unit density spheres. Large differences were identified between mean organ doses calculated in the test mice using RAPID and those derived in the MOBY phantom. Mean absorbed dose percent errors in organs ranged between 0.3{\%} and 333{\%}. Overall, mass scaling improved agreement between MOBY phantom calculations and RAPID, where percent errors were all less than 26{\%}, with the exception of the lung in which percent errors reached values of 48{\%}. Percent errors in mean tumor doses in the test mice and unit density spheres were less pronounced but still ranged between 8{\%} and 23{\%}. This work demonstrates the limitations of using pre-computed S-values in computational phantoms to predict organ doses in small animals from theranostic procedures. RAPID can generate accurate 3D dose distributions in small animals and in turn offer much greater insight on the ability of a given theranostic agent to image and treat diseases.",
keywords = "Monte Carlo, dosimetry, internal, nuclear medicine, radiation therapy",
author = "Bryan Bednarz and Joseph Grudzinski and Ian Marsh and Abby Besemer and Dana Baiu and Jamey Weichert and Mario Otto",
year = "2018",
month = "4",
day = "1",
doi = "10.1097/HP.0000000000000789",
language = "English (US)",
volume = "114",
pages = "450--459",
journal = "Health Physics",
issn = "0017-9078",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents

AU - Bednarz, Bryan

AU - Grudzinski, Joseph

AU - Marsh, Ian

AU - Besemer, Abby

AU - Baiu, Dana

AU - Weichert, Jamey

AU - Otto, Mario

PY - 2018/4/1

Y1 - 2018/4/1

N2 - There is a growing need to estimate the absorbed dose to small animals from preclinical investigations involving diagnostic and therapeutic radiopharmaceuticals. This paper introduces a Monte Carlo-based dosimetry platform called RAPID, which is capable of calculating murine-specific three-dimensional (3D) dose distributions. A comparison is performed between absorbed doses calculated with RAPID and absorbed doses calculated in a commonly used reference mouse phantom called MOBY. Four test mice containing different xenografts underwent serial PET/CT imaging using a novel diagnostic therapy (theranostic) agent NM404, which can be labeled with 124I for imaging or 131I for therapy. Using the PET/CT data, 3D dose distributions from 131I-NM404 were calculated in the mice using RAPID. Mean organ doses in these four test mice were compared to mean organ doses derived by using two previously published 131I S-values datasets in MOBY. In addition, mean tumor doses calculated in RAPID were compared to mean organ doses derived from unit density spheres. Large differences were identified between mean organ doses calculated in the test mice using RAPID and those derived in the MOBY phantom. Mean absorbed dose percent errors in organs ranged between 0.3% and 333%. Overall, mass scaling improved agreement between MOBY phantom calculations and RAPID, where percent errors were all less than 26%, with the exception of the lung in which percent errors reached values of 48%. Percent errors in mean tumor doses in the test mice and unit density spheres were less pronounced but still ranged between 8% and 23%. This work demonstrates the limitations of using pre-computed S-values in computational phantoms to predict organ doses in small animals from theranostic procedures. RAPID can generate accurate 3D dose distributions in small animals and in turn offer much greater insight on the ability of a given theranostic agent to image and treat diseases.

AB - There is a growing need to estimate the absorbed dose to small animals from preclinical investigations involving diagnostic and therapeutic radiopharmaceuticals. This paper introduces a Monte Carlo-based dosimetry platform called RAPID, which is capable of calculating murine-specific three-dimensional (3D) dose distributions. A comparison is performed between absorbed doses calculated with RAPID and absorbed doses calculated in a commonly used reference mouse phantom called MOBY. Four test mice containing different xenografts underwent serial PET/CT imaging using a novel diagnostic therapy (theranostic) agent NM404, which can be labeled with 124I for imaging or 131I for therapy. Using the PET/CT data, 3D dose distributions from 131I-NM404 were calculated in the mice using RAPID. Mean organ doses in these four test mice were compared to mean organ doses derived by using two previously published 131I S-values datasets in MOBY. In addition, mean tumor doses calculated in RAPID were compared to mean organ doses derived from unit density spheres. Large differences were identified between mean organ doses calculated in the test mice using RAPID and those derived in the MOBY phantom. Mean absorbed dose percent errors in organs ranged between 0.3% and 333%. Overall, mass scaling improved agreement between MOBY phantom calculations and RAPID, where percent errors were all less than 26%, with the exception of the lung in which percent errors reached values of 48%. Percent errors in mean tumor doses in the test mice and unit density spheres were less pronounced but still ranged between 8% and 23%. This work demonstrates the limitations of using pre-computed S-values in computational phantoms to predict organ doses in small animals from theranostic procedures. RAPID can generate accurate 3D dose distributions in small animals and in turn offer much greater insight on the ability of a given theranostic agent to image and treat diseases.

KW - Monte Carlo

KW - dosimetry, internal

KW - nuclear medicine

KW - radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85043230588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043230588&partnerID=8YFLogxK

U2 - 10.1097/HP.0000000000000789

DO - 10.1097/HP.0000000000000789

M3 - Article

C2 - 29481536

AN - SCOPUS:85043230588

VL - 114

SP - 450

EP - 459

JO - Health Physics

JF - Health Physics

SN - 0017-9078

IS - 4

ER -